flow trial semaglutide kidney outcomes hazard ratio 0.76 nejm 2024 🔴Cardiovascular with by severity of chronic disease in type 2 diabetes: the trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants 2. dr. Nanang - New

Gentle hair care: Minimize heat styling, harsh chemicals, and tight hairstyles

A Lithium GLP-1 Interaction More evidence of a serious drug interaction STUDY: Patarroyo-Rodriguez LP et al, J Clin Psychopharmacol 2026 STUDY TYPE: Case report FUNDING: National Center for Advancing Translational Science (NCATS) Background GLP-1 and GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound) cause nausea, vomiting, and dehydration, especially during dose escalation

PMCID: PMC5768894

Eligibility is determined individually by a licensed provider

Wilson disease is caused by a genetic defect that allows copper to accumulate in the liver and other organs